/
/
Opbygge en høj overførselshastighed Screening Platform til at vurdere heterogenitet af HER2 genet forstærkning i brystkræft
A subscription to JoVE is required to view this content. Sign in or start your free trial.
1Division of Pathology,Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 2School of Medicine,University of Milan, 3School of Biology,University of Pavia, 4Division of Breast Surgery,Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, 5Division of Medical Oncology,Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, 6Department of Biomedical, Surgical, and Dental Sciences,University of Milan
Chapters
- 00:05Title
- 01:24Design and Construct Tissue Microarrays (TMAs) Based on the Kononen Technique
- 06:20Silver In Situ Hybridization (SISH) Analysis of Human Epidermal Growth Factor Receptor 2 (HER2)
- 09:11Results: Analysis of Heterogeneity of HER2 Gene Amplification in Breast Cancers
- 10:00Conclusion
Heterogen fordeling af HER2-positive celler kan observeres i en delmængde af brystkræft og genererer kliniske dilemmaer. Her introducerer vi en pålidelig og omkostningseffektiv protokol for at definere, kvantificere og sammenligne HER2 intra-tumor genetiske heterogenitet i en lang række uensartet forarbejdede brystkræft.
